Brief: Titan Pharmaceuticals Says Co Implemented Plan To Reduce Expenses & Conserve Capital
02/06/2022 22:34
June 2 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS - ON JUNE 1, 2022, CO IMPLEMENTED
PLAN TO
REDUCE EXPENSES & CONSERVE CAPITAL
* TITAN PHARMACEUTICALS- MARC RUBIN, EXECUTIVE CHAIRMAN,
KATE
BEEBE DEVARNEY, PRESIDENT & COO, AGREED TO WAIVE 40% OF BASE
SALARIES FOR NEXT 6 MONTHS
Further company coverage: TTNP.O
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.